a n d
c h a n g e d
h o w
I
m a n a g e
m y
t y p e
2
d i a b e t e s .
V ic to z a ® m a y h e l p
l o w e r b l o o d s u g a r — a n d c a n e v e n
l o w e r y o u r w e i g h t .
N o n - in s u lin V ic to z a ® ,
a l o n g w i t h
e a t i n g
r i g h t a n d
s t a y i n g
a c t i v e ,
c a n
m a k e a
r e a l
d i f f e r e n c e . A n d V ic to z a ® is u s e d
o n c e a
d a y a n y t i m e , w i t h
o r w i t h o u t f o o d .
P l u s ,
i t h e l p s k e e p i m p o r t a n t c e l l s
i n y o u r p a n c r e a s t h a t c o n t r o l
b l o o d s u g a r —
c a l l e d
b e t a c e l l s — w o r k i n g t h e w a y t h e y s h o u l d . V ic to z a ® w o r k s
b y t a r g e t i n g
b e t a c e lls t o
h e l p
l o w e r b l o o d s u g a r w h e n
it is h i g h .
I f y o u ' r e
r e a d y f o r a
c h a n g e ,
t a l k
t o
y o u r d o c t o r a b o u t V i c t o z a ® t o d a y .
o r
p la n t o
b r e a s t f e e d .
It is
u n k n o w n
if V icto za® w ill
h a r m y o u r u n b o r n b a b y o r if V ictoza® p a s s e s in to y o u r
b r e a s t m ilk .
Y o u r risk f o r g e tt in g h y p o g ly c e m ia , o r lo w b lo o d s u g a r,
is h i g h e r if y o u t a k e V icto za® w ith a n o t h e r m e d ic in e
t h a t c a n c a u s e lo w b lo o d s u g a r, s u c h a s a s u lf o n y lu r e a .
T h e d o s e o f y o u r s u lf o n y lu r e a m e d ic in e m a y n e e d t o
b e lo w e r e d w h ile t a k i n g V ictoza® .
T h e m o s t c o m m o n s id e e f f e c t s w ith V icto za® in c lu d e
h e a d a c h e ,
n a u s e a ,
d i a r r h e a ,
a n d
r e s i s t a n c e
t o
l i r a g l u t i d e
( a n t i b o d y
f o r m a t i o n ) .
N a u s e a
is
m o s t
c o m m o n w h e n f ir s t s t a r t i n g V ictoza® ,
b u t d e c r e a s e s
o v e r t i m e
in
m o s t
p e o p l e .
I m m u n e
s y s t e m - r e l a t e d
r e a c t i o n s ,
i n c l u d i n g
h iv e s ,
w e r e
m o r e
c o m m o n
in
p e o p l e
t r e a t e d
w i t h
V ic to z a ®
c o m p a r e d
t o
p e o p l e
t r e a t e d
w i t h
o t h e r
d i a b e t e s drugs in
m e d ic a l s tu d ie s .
P lease see B rie f S u m m a ry o f Im p o r ta n t P a tie n t
In fo rm a tio n o n n e x t p a g e .
If you need assistance with prescription drug costs, help may be
available. Visit pparx.org or call 1-888-4PPA-NOW.
You are encouraged to report negative side effects of prescription drugs
to the FDA. Visit fda.gov/medwatch or call 1-800-FDA-1088.
Victoza® is a registered trademark of Novo Nordisk A/S.
© 2010 Novo Nordisk A/S. 140206 July 2010
T o
l e a r n
m o r e ,
v i s i t v i c t o z a . c o m o r
c a l l
1 - 8 7 7 - 4 - V I C T O Z A ( 1 - 8 7 7 - 4 8 4 - 2 8 6 9 ) .
N o n - i n s u l i n
•
O n c e - d a i l y
liraglutide (rDNA origin) injection
M a k e
a
C h a n g e
T o d a y
